contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


braincool-ab-publ-the-first-patient-has-been-treated-with-rhinochillr-system-in-the-pivotal-cottis-2-study

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

BrainCool operates in the medical technology sector. The company develops products for medical cooling of the brain. The technology is developed as cooling pads that are applied to different parts of the patient's body, where the system controls body temperature. The products are used in the treatment of various serious conditions including stroke, cardiac arrest, as well as concussion and migraine. BrainCool was founded in 2010 and is headquartered in Lund.

BrainCool

BrainCool AB (publ) can announce that the first patient has been treated with RhinoChill® System and BrainCool™ System during a thrombectomy procedure in the COTTIS 2 study. The COTTIS 2 (Combination...

<div class="mfn-body"><p>BrainCool AB (publ) can announce that the first patient has been treated with RhinoChill® System and BrainCool™ System during a thrombectomy procedure in the COTTIS 2 study.<br>&nbsp;<br>The COTTIS 2 (Combination of Targeted temperature management and Thrombectomy after acute Ischemic Stroke) clinical trial intends to measure the outcome in acute stroke patients with large vessel occlusion treated with the combination of hypothermia and thrombectomy.<br>&nbsp;<br>On June 28th, 2024, BrainCool AB communicated in a press release that all the criteria had been fulfilled to enroll the first patient in the pivotal COTTIS 2 trial, which is equivalent to a phase 3 clinical trial. COTTIS 2 is a multicenter randomized clinical trial with a total of 400 patients. Professor Dr. Jürgen Bardutzky at the University Hospital of Freiburg is the principal investigator of COTTIS 2.<br>&nbsp;<br>Please see the press release mentioned above for more details regarding COTTIS 2 and ischemic stroke.<br>&nbsp;<br><a rel="noopener" href="https://www.braincool.se/press-releases-page?slug=braincool-ab-publ-the-first-patient-can-now-be-enrolled-in-the-pivotal-cottis-2-study">https://www.braincool.se/press-releases</a></p></div><div class="mfn-footer mfn-46d5b376c4f5"><p><strong class="mfn-heading-1">Contact</strong><br><strong>For more information</strong><br>Jon Berg - CEO<br>+46 722 50 91 19<br>E-mail: jon.berg@braincool.se</p></div><div class="mfn-footer mfn-about mfn-65972121fba8"><p><strong class="mfn-heading-1">About Us</strong><br>BrainCool AB (publ) is an innovative medical device company that develops, markets, and sells leading medical cooling systems for indications and areas with significant medical benefits within the healthcare sector. BrainCool AB (publ) is based in Lund, Sweden, and its share is listed on Nasdaq First North Growth Market, named “BRAIN”.<br>Eminova Fondkommission AB is the company’s Certified Adviser.</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/3bc1a7c5-0641-4dda-ae3a-0516dd4f2e6c/braincool-ab-publ-the-first-patient-has-been-treated-with-rhinochill-r-system-in-the-pivotal-cottis-2-study.pdf" class="mfn-generated mfn-primary">BrainCool AB (publ) – the first patient has been treated with RhinoChill® System in the pivotal COTTIS 2 study</a></p></div>

BrainCool AB (publ) – the first patient has been treated with RhinoChill® System in the pivotal COTTIS 2 study